Potential target for reversing drug resistance in ovarian cancer identified

 For the 314,000 people diagnosed with ovarian cancer each year, hope often comes in the form of platinum-based drugs such as cisplatin.

Cisplatin causes the death of quick-dividing tumour cells, so it is a potent first-line defence in the treatment of the often fatal disease.

However, over half of ovarian cancer patients develop recurrence and become resistant to cisplatin and other platinum-based chemotherapies, contributing to the five-year survival rate of 31%.

THE's World University Rankings 2024 Masterclass

Unravelling the Wide-Ranging Impacts of Glyphosate on Ecosystems and Pollinators

Glyphosate, a widely-used chemical compound in herbicides and its wide-ranging impacts on ecosystems and pollinators will be the research focus at the University of Turku. In their proposals, the researchers highlight the importance of comprehensively understanding the problem and stress the significance of collaboration between researchers, farmers and decision-makers to address the issue effectively. The research has received significant funding from the Research Council of Finland and Sakari Alhopuro Foundation.